Article Text

Download PDFPDF
Clinical features of type 2 Stickler syndrome
  1. A V Poulson1,
  2. J M M Hooymans2,
  3. A J Richards3,
  4. P Bearcroft4,
  5. R Murthy1,
  6. D M Baguley5,
  7. J D Scott1,
  8. M P Snead1
  1. 1Vitreoretinal Service, Addenbrooke’s NHS Trust, Cambridge, UK
  2. 2Department of Ophthalmology, University Hospital of Groningen, Groningen, Netherlands
  3. 3Department of Pathology, University of Cambridge, Cambridge, UK
  4. 4Department of Radiology, Addenbrooke’s NHS Trust, Cambridge, UK
  5. 5Department of Audiology, Addenbrooke’s NHS Trust, Cambridge, UK
  1. Correspondence to:
 M P Snead
 Vitreoretinal Service, Box 41, Addenbrooke’s NHS Trust, Hills Road, Cambridge, CB2 2QQ, UK;

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The Stickler syndromes1–8 (hereditary arthro-ophthalmopathy; McKusick nos. 108300 and 604841) are one of the more frequently occurring groups of chondrodysplasias and are the commonest inherited cause of rhegmatogenous retinal detachment.9 The majority of patients and pedigrees exhibit the type 1 or “membranous” vitreous phenotype10,11 and harbour mutations in the gene for type II collagen (COL2A1).12–21 While not all mutations in type II collagen result in the membranous vitreous anomaly,22,23 when it is exhibited it appears to be congenital and provides a useful basis for mutant locus assignment. This is particularly helpful for sporadic cases where linkage is impossible, and especially in those individuals with mild or minimal systemic involvement where the diagnosis might otherwise be overlooked.19,24–26 Other pedigrees exhibit a different “beaded” vitreous phenotype and are linked to a different locus.11,27 We reported the first mutation in the gene encoding the α1 chain of type XI collagen (COL11A1) in one of these pedigrees28 and this locus was confirmed in other pedigrees,29,30 and is now known as type 2 Stickler syndrome (McKusick no. 604841). The intimate post-translational molecular associations between types II and XI collagen form the foundation of the close clinical overlap between these two sub-groups of Stickler syndrome, but the extent of this clinical overlap and variation remains to be defined. Whilst type 1 Stickler syndrome pedigrees have a particularly high risk of blindness through giant retinal tear and retinal detachment, Annunen et al suggest that patients with COL11A1 mutations are at a low risk of retinal detachment and have a higher incidence of midfacial hypoplasia.29 This would be an important prognostic difference if confirmed. Here we wish to report the first description of the ophthalmic, oro-facial, audiologial, skeletal, and …

View Full Text


  • This research is funded by grants from The Guide Dogs for the Blind Association, The Isaac Newton Trust, The Stanley Thomas Johnson Foundation, Action Medical Research and The University of Cambridge Retinal Research Fund.

  • Conflict of interest: none declared.